Viadent usage and oral leukoplakia: A spurious association

Regulatory Toxicology and Pharmacology

Volumn 30, Issue 3, 1999, Pages 182-196

  Munro, Ian C ^a   Delzell, Elizabeth S ^b   Nestmann, Earle R ^a   Lynch, Barry S ^a  

^a Cantox Health Sciences International   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SANGUINARINE;

ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; GINGIVITIS; HUMAN; LEUKOPLAKIA; MOUTH HYGIENE; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

ANIMALIA; SANGUINARIA;

EID: 0033392579     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1999.1339     Document Type: Article

References (126)

1. Abbas, D. K., Thrane, P., and Othman, S. J. (1985). Effectiveness of veadent as a plaque-inhibiting mouthwash. Scand. J. Dent. Res. 93, 494-497. [Cited in Laster and Lobene, 1990]
2. Afseth, J., and Rölla, G. (1987). Clinical experiments with a mouthrinse containing sanguinarine chloride. Caries Res. 21, 285-288. [Cited in Laster and Lobene, 1990]
3. Alworth, K., Shanahan, R. W., and Dorman, N. (1984a). Final Report - Clinical Safety Evaluation of Veadent Oral Rinse, Lot No. 434. Repeated Insult Patch Test. Submitted to Vipont Laboratories, Fort Collins, CO.
4. Alworth, K., Shanahan, R. W., and Dorman, N. (1984b). Final Report - Clinical Safety Evaluation of CSM 003-057C Experimental Dentifrice. Repeated Insult Patch Test. Submitted to Vipont Laboratories, Fort Collins, CO.
5. Alworth, K., Shanahan, R. W., and Dorman, N. (1984c). Final Report - Clinical Safety Evaluation of CSM 002-089 Veadent With 15% CA, 4/11/84. Repeated Insult Patch Test. Submitted to Vipont Laboratories, Fort Collins, CO.
6. Alworth, K., Shanahan, R. W., and Dorman, N. (1985a). Final Report - Clinical Safety Evaluation of Viadent Oral Rinse. Repeated Insult Patch Test. Submitted to Vipont Laboratories, Fort Collins, CO.
7. Alworth, K., Shanahan, R. W., and Dorman, N. (1985b). Final Report - Clinical Safety Evaluation of Viadent Dentifrice/New Formula/New Flavor. Repeated Insult Patch Test. Submitted to Vipont Laboratories, Fort Collins, CO.
8. Alworth, K., Shanahan, R. W., and Dorman, N. (1985c). Final Report - Clinical Safety Evaluation of Viadent Oral Rinse CSM 005-020 New Flavor 3/21/85. Submitted to Vipont Laboratories, Fort Collins, CO.
9. Alworth, K., Shanahan, R. W., and Dorman, N. (1985d). Final Report - Clinical Safety Evaluation of CSM 005-020 Viadent New Flavor 3/21/85. Submitted to Vipont Laboratories, Fort Collins, CO.
10. Anderson, D. (1993). Genetic Toxicology. In Experimental Toxicology: The Basic Issues (Anderson, D., and Conning, D. M., Eds.), 2nd ed. R. Soc. Chem., Cambridge, England.
11. Babich, H., Zuckerbraun, H. L., Barber, I. B., Babich, S. B., and Borenfreund, E. (1996). Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol. Toxicol. 78(6), 397-403.
12. Barczynski, J. L., Fletcher, R. D., Segal, A. H., and Conway, J. C. (1987). Viadent, ethanol, and pH effects upon gingival epithelial-like cells, in vitro. J. Periodontol. 58(9), 622-627.
13. Bouquot, J. E. (1994). Oral Leukoplakia and Erythroplakia: A Review and Update. PP&A 6(6), 9-17.
14. Bouquot, J. E., and Gorlin, R. J. (1986). Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg. Oral Med. Oral Pathol. 61, 373-381.
15. Brusick, D. (1994). Genetic Toxicology. In Principles and Methods of Toxicology (Hayes, A. W., Ed.), 3rd ed., pp. 545-577. Raven Press, New York, NY.
16. Damm, D. D., Curran, A., White, D. K., and Drummond, J. F. (1999). Leukoplakia of the maxillary vestibule - An association with Viadent? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87, 61-66.
17. Das, M., and Khanna, S. K. (1997). Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Crit. Rev. Toxicol. 27, 273-297.
18. Exxon (1992a). Primary Dermal Irritation Study in Rabbits. Exxon Biomedical Sciences, Inc., East Millstone, NJ, Project No. 173304. Prepared for Colgate-Palmolive Co., Piscataway, NJ.
19. Exxon (1992b). Primary Dermal Irritation Study in Rabbits. Exxon Biomedical Sciences, Inc., East Millstone, NJ, Project No. 173404. Prepared for Colgate-Palmolive Co., Piscataway, NJ.
20. Exxon (1993a). 30-Day Subchronic Oral Toxicity Study in Rats. Exxon Biomedical Sciences, Inc., East Millstone, NJ, Project No. 173370. Prepared for Colgate-Palmolive Co., Piscataway, NJ.
21. Exxon (1993b). 30-Day Subchronic Oral Toxicity Study in Rats. Exxon Biomedical Sciences, Inc., East Millstone, NJ, Project No. 173470. Prepared for Colgate-Palmolive Co., Piscataway, NJ.
22. FDRL (1981a). Acute I.V. Injection LD50 Assay of Sanguinarine Chloride in Rats. Food and Drug Research Laboratories, Inc., Study No. 6810A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-07.
23. A. Submitted to Vipont Research Laboratories, Inc., Fort Collins, CO, Study No. VPTS-04.
24. FDRL (1981c). 14-Day Dietary Toxicity Study with MHD-VI-47-1 in Sprague-Dawley Rats. Food and Drug Research Laboratories, Inc., Study No. 6821. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-06.
25. B. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-06.
26. B. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-06.
27. FDRL (1981f). 28-Day Subchronic Oral Mucosal Irritancy Study of Three Sanguinarine Chloride Preparations in Dogs. Food and Drug Research Laboratories, Inc., Study No. 6822. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-06.
28. A. Submitted to Vipont Chemical Co., Fort Collins, CO.
29. B. Submitted to Vipont Chemical Co., Fort Collins, CO.
30. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-13.
31. A. Submitted to Vipont Chemical Co., Fort Collins, CO.
32. FDRL (1982e). Final Report - Clinical Safety Evaluation of Viadent Toothpaste, RTB-111-77-18. Food and Drug Research Laboratories, Inc. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-06.
33. FDRL (1982f). Mucous Membrane Irritancy Assay: Hamster Cheek Pouch Method. Food and Drug Research Laboratories, Inc., Study No. 7293. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-09.
34. FDRL (1982g). Mucous Membrane Irritancy Assay: Hamster Cheek Pouch Method. Food and Drug Research Laboratories, Inc., Study No. 7457. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-15.
35. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-17.
36. B. Submitted to Vipont Research Laboratories, Inc., Fort Collins, CO, Study No. VPTS-18.
37. A. Submitted to Vipont Chemical Co., Fort Collins, CO.
38. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-23.
39. FDRL (1983e). Mucous Membrane Irritancy Study of Dentifrice Viadent (Hamster Cheek Pouch Method). Food and Drug Research Laboratories, Inc., Study No. 7794. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-31.
40. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-33.
41. B. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-2.
42. FDRL (1984a). 30-Day Oral Toxicity Study of RRJ-11-091 in Sprague-Dawley Rats. Food and Drug Research Laboratories, Inc., Study No. 8266. Submitted to Vipont Research Laboratories, Inc., Fort Collins, CO, Study No. VPTS-33.
43. FDRL (1984b). Mucous Membrane Irritancy Study of Viadent 0.2% (CSM 001-040 A) and Hibitane Lot #NU083 (Hamster Cheek Method). Food and Drug Research Laboratories, Inc., Study No. 7936. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-36.
44. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-39.
45. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-54.
46. C. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-54.
47. A. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VPTS-44.
48. FDRL (1985b). Acute Oral Toxicity Study of CSM 005-020 Vidaent Oral Rinse, Viadent - New Flavour in Sprague-Dawley Rats. Food and Drug Research Laboratories, Inc. [Cited in Frankos et al., 1990]
49. FDRL (1986). Mucous Membrane Irritancy Assay of Viadent Experimental Formula JAW-003-007 and Colgate Winter Fresh Gel Toothpaste (Hamster Cheek Pouch Method). Food and Drug Research Laboratories, Inc., Study No. 8891. Submitted to Vipont Chemical Co., Fort Collins, CO, Study No. VS-45.
50. Frankos, V. H., Brusick, D. J., Johnson, E. M., Maibach, H. I., Munro, I., Squire, R. A., and Weil, C. S. (1990). Safety of sanguinaria extract as used in commercial toothpaste and oral rinse products. J. Can. Dent. Assoc. (Journal de l'Association Dentaire Canadienne) 56(Suppl. 7), 41-47.
51. Godowski, J. K. (1989). Antimicrobial action of sanguinarine. J. Clin. Dent. I(4), 96-101.
52. Greenfield, W., and Cuchel, S. J. (1984). The use of an oral rinse and dentrifice as a system for reducing dental plaque. Compend. Cont. Educ. Dent. 5, S82-S86.
53. Grossman, E., Meckel, A. H., Isaacs, R. L., Ferretti, G. A., Sturzenberger, O. P., Bollmer, B. W., Moore, D. J., Lijana, R. C., and Manhart, M. D. (1989). A clinical comparison of antibacterial mouthrinses: Effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. J. Periodontol. 60, 435-440. [Cited in Laster and Lobene, 1990]
54. Hakim, S. A. E. (1968). Sanguinarine. A carcinogenic contaminant in Indian edible oils. Indian J. Cancer 10, 183-197.
55. Hakim, S. A. (1970). Death, cardio-myopathy, symptomless glaucoma and cancer from edible oils containing Argemone. Maharashtra Med. J. 17, 109-130.
56. Hakim, S. A. E., Mijovik, V., and Walker, J. (1961). Experimental transmission of sanguinarine in milk: Detection of a metabolic product. Nature 189, 201-204.
57. Hannah, J. J., Johnson, J. D., and Kuftinec, M. M. (1989). Long-term clinical evaluation of toothpaste and oral rinse containing sanguinaria extract in controlling plaque, gingival inflammation, and sulcular bleeding during orthodontic treatment. Am. J. Orthodont. Dent. Orthop. 96(3), 199-207.
58. Harkrader, R. J., Reinhart, P. C., Rogers, J. A., Jones, R. R., Wylie, R. E., Lowe, B. K., and McEvoy, R. M. (1990). The history, chemistry and pharmacokinetics of sanguinaria extract. J. Can. Dent. Assoc. (Journal de l'Association Dentaire Canadienne) 56(Suppl. 7), 7-12.
59. Harper, D. S., Mueller, L. J., Fine, J. B., Gordon, J., and Laster, L. L. (1990a). Clinical efficacy of a dentifrice and oral rinse containing sanguinaria extract and zinc chloride during 6 months of use. J. Peridontol. 61(6), 352-358.
60. Harper, D. S., Mueller, L. J., Fine, J. B., Gordon, J., and Laster, L. L. (1990b). Effect of 6 months use of a dentifrice and oral rinse containing sanguinaria extract and zinc chloride upon the microflora of the dental plaque and oral soft tissues. J. Periodontol. 61(6), 359-363.
61. Hoang-Trong, F. (1991). Determination of Sanguinarine Chloride Metabolites. Internship Report. Prepared at ATRIX Laboratories, Inc. Fort Collins, CO.
62. ICPEMC (1982). Mutagenesis Testing as an Approach to Carcinogenesis. Elsevier Biomedical Press, Amsterdam, Netherlands. Final Report of ICPEMC Committee No. 2.
63. IRDC (1986a). Acute Oral Toxicity Study in Rats - Limit Test -Viadent Oral Rinse. International Research and Development Corporation, Mattawan, MI, Study No. 558-003. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VPTS-55.
64. IRDC (1986b). Oral Mucous Membrane Irritation Study in Rats. International Research and Development Corp., Mattawan, MI, Study No. 425-008. Submitted to Colgate-Palmolive Company.
65. IRDC (1987a). Acute Oral Toxicity Study in Rats - Limit Test -Viadent Oral Rinse. International Research and Development Corp., Mattawan, MI, Study No. 558-006. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-07.
66. IRDC (1987b). Thirteen-Week Oral Toxicity Study in Rats -Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-001. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
67. IRDC (1987c). Four-Week Exploratory Dietary Toxicity Study in Rats December 21. [Cited in Frankos et al., 1990]
68. IRDC (1988a). Acute Oral Toxicity Study in Rats - Sanguinarine Chloride. International Research and Development Corp., Mattawan, MI, Study No. 558-020. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-21.
69. IRDC (1988b). Thirteen-Week Oral Toxicity Study in Cynomolgus Monkeys - Sanguinarine Chloride. International Research and Development Corp., Mattawan, MI, Study No. 558-014. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-16.
70. IRDC (1988c). Range-Finding Developmental Toxicity Study in New Zealand White Rabbits - Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-007. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
71. IRDC (1988d). Study of Fertility and General Reproductive Performance in Rats - Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-004. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-03.
72. IRDC (1988e). Developmental Toxicity Study in Rats - Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-009. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-11.
73. IRDC (1988f). Perinatal and Postnatal Study in Rats - Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-010. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-12.
74. IRDC (1989a). Developmental Toxicity Study in New Zealand White Rabbits - Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-008. Submitted to Vipont Laboratories, Inc., Fort Collins, CO, Study No. VRTS-10.
75. IRDC (1989b). Two-Year Oral Oncogenicity Study in Rats-Sanguinarine Extract. International Research and Development Corp., Mattawan, MI, Study No. 558-002. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
76. IRDC (1990a). Two Year Dietary Toxicity and Oncogenicity Study in Rats. International Research and Development Corp., Mattawan, MI, Study No. 558-015. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
77. IRDC (1990b). Dermal Sensitization Study in the Albino Guinea Pig (Buehler). International Research and Development Corp., Mattawan, MI, Study No. 558-025. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
78. IRDC (1990c). Gingival Irritation Study in Dogs. International Research and Development Corp., Mattawan, MI, Study No. 558-023. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
79. IRDC (1993a). Oral Mucosal Irritation Study in Rats. International Research and Development Corp., Mattawan, MI, Study No. 425-013. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
80. IRDC (1993b). Oral Mucosal Irritation Study in Rats. International Research and Development Corp., Mattawan, MI, Study No. 425-014. Submitted to Vipont Laboratories, Inc., Fort Collins, CO.
81. Klewansky, P., and Vernier, D. (1984). Sanguinarine and the control of dental plaque in dental practice. Comp. Cont. Ed. Dent. 5, 94-97. [Cited in Laster and Lobene, 1990]
82. Klewansky, P., and Roth, D. (1986). Sanguinaria in control of bleeding in periodontal patients. Compend. Cont. Educ. Dent. 7, S218-S220.
83. Kopczyk, R., Abrams, J., Brown, A., Matheny, J., and Kaplan, A. (1990). Evaluation of a sanguinaria-containing regimen with and without food. J. Dent. Res. 69. [Abstract #1135] [Cited in Kuftinec et al., 1990]
84. Kopczyk, R. A., Abrams, H., Brown, A. T., Matheny, J. L., and Kaplan, A. J. (1991). Clinical and microbiological effects of sanguinaria-containing mouthrinse and dentifrice with and without fluoride during 6 months of use. J. Periodontol. 62, 617-622.
85. Kuftinec, M. M., Mueller-Joseph, L. J., and Kopczyk, R. A. (1990). Sanguinaria toothpaste and oral rinse regimen clinical efficacy in short- and long-term trials. J. Can. Dent. Assoc. 56(7), 31-35.
86. Lang, P. L. (1992). Spontaneous Neoplastic Lesions and Selected Nonneoplastic Lesions in the Crl:CD BR Rat. Prepared for Charles River Laboratories.
87. Laster, L. L., and Lobene, R. R. (1990). New perspectives on sanguinaria clinicals: Individual toothpaste and oral rinse testing. J. Can. Dent. Assoc. 56(7), 19-23.
88. Lin, Y.-J., McPherson, B. P., Rizvi, P. Y., Smith, N. L., and Taylor, C. D. (1989). Investigation of Benz(c)acridine Formation From Sanguinarine and Sanguinaria Extract. Report No. 3704. Submitted to Colgate-Palmolive Company, Piscataway, NJ.
89. Litton Bionetics (1977). Mutagenicity Evaluation of Sanguinarine Chloride. ID# RAL-I-1961-1. Final Report. Submitted by Litton Bionetics, Inc. Kensington, MD. LBI Project No. 263.
90. Lobene, R. R., Soparkar, P. M., and Newman, M. B. (1986). The effects of a sanguinaria dentrifice on plaque and gingivitis. Compend. Cont. Educ. Dent. 7, S185-S188.
91. Lord, G., Goldenthal, E. I., and Meyer, D. L. (1989). Sanguinarine and the controversy concerning its relationship to glaucoma in epidemic dropsy. J. Clin. Dent. I(4), 110-115.
92. MAI (1986a). Salmonella/Mammalian-Microsome Plate Incorporation Mutagenicity Assay (Ames Test) and Escherichia coli WP2uvrA Reverse Mutation Assay. Microbiological Associates, Inc. Bethesda, Maryland. Study No. T4897.501. Submitted to Vipont Laboratories, Fort Collins, CO.
93. MAI (1986b). Salmonella/Mammalian-Microsome Plate Incorporation Mutagenicity Assay (Ames Test) and Escherichia coli WP2uvrA Reverse Mutation Assay. Microbiological Associates, Inc. Bethesda, MD. Study No. T4896.501. Submitted to Vipont Laboratories, Fort Collins, CO.
94. MAI (1986c). Salmonella/Mammalian-Microsome Plate Incorporation Mutagenicity Assay (Ames Test) For Mutagenic Metabolites in Rodent Urine. Microbiological Associates, Inc. Bethesda, MD. Study No. T4932.520004-T4937.520004. Submitted to Vipont Laboratories, Fort Collins, CO.
95. MAI (1987a). Unscheduled DNA Synthesis in Rat Primary Hepatocytes. Microbiological Associates, Inc. Bethesda, MD. Study No. T5258.380. Submitted to Vipont Laboratories, Fort Collins, CO.
96. MAI (1987b). Micronucleus Cytogenetic Assay in Mice - Final Report. Microbiological Associates, Inc. Bethesda, MD. Study No. T5258.120. Submitted to Vipont Laboratories, Fort Collins, CO.
97. Maiti, M., Nandi, R., and Chaudhuri, K. (1984). Interaction of sanguinarine with natural and synthetic deoxyribonucleic acids. Indian J. Biochem. Biophys. 21, 158-165.
98. Mauriello, S. M., and Bader, J. D. (1988). Six-month effects of a sanguinarine dentrifice [sic] on plaque and gingivitis. Comp. Cont. Ed. Dent. 7, 185-188. [Cited in Laster and Lobene, 1990]
99. Miller, R. A., Mciver, J. E., and Gunsolley, J. C. (1988). Effects of sanguinaria extract on plaque retention and gingival health. J. Clin. Orthodont. XXII(5), 304-307.
100. Nygaard-Oestby, P., and Persson, I. (1984). Evaluation of sanguinarine chloride in control of plaque in the dental practice. Compend. Cont. Educ. Dent. 5, S90-S93.
101. +/- mutation assay using suspension treatment and soft age cloning: Results for 10 chemicals. Cell Biol. Toxicol. 9(3), 243-257.
102. Palcanis, K. G., Sarbin, A. G., Koertge, T. E., Brooks, C. N., and Gunsolley, J. C. (1990). Longitudinal evaluation and the effects of sanguinarine on plaque and gingivitis. Gen. Dent. Jan-Feb, 17-19. [Cited in Laster and Lobene, 1990]
103. Parsons, L. G., Thomas, L. G., Southard, G. L., Woodall, I. R., and Jone, B. J. B. (1987). Effect of sanguinaria extract on established plaque and gingivitis when supragingivally delivered as a manual rinse or under pressure in oral irrigator. J. Clin. Peridontol. 14, 381-385. [Cited in Laster and Lobene, 1990]
104. Patel, A. J. (1989). The effects of chlorhexidine and sanguinarine on gingivitis and plaque in orthodonti patients. Master's Thesis presented to Saint Louis University. [Cited in Kuftinec et al., 1990]
105. Pharmakon (1985a). CHQ/HGRPT Mammalian Cell Forward Gene Mutation Assay. Pharmakon Research International, Inc. Submitted to Vipont Laboratories, Fort Collins, CO.
106. Pharmakon (1985b). Rat Hepatocyte Primary Culture/DNA Repair Test Pharmakon Research International, Inc. Submitted to Vipont Laboratories, Fort Collins, CO.
107. Pharmakon (1985c). Cardiovascular Studies in Dogs. PH 247-ETC-001-85. Pharmakon Laboratories, Waverly, PA. Submitted to Vipont Research Laboratories, Inc., Fort Collins, CO.
108. Saran, A., Srivastava, S., Coutinho, E., and Maiti, M. (1995). 1H NMR investigation of interaction of berberine and sanguinarine with DNA. Indian J. Biochem. Biophys. 32, 74-77.
109. Schonfield, S. E., Famoush, A., and Wilson, S. G. (1986). In vivo antiplaque activity of a sanguinarine-containing dentrifice: Comparison with conventional toothpastes. J. Periodont. Res. 21, 298-303. [Cited in Laster and Lobene, 1990]
110. Sen, A., Ray, A., and Maiti, M. (1996). Thermodynamics of the interaction of sanguinarine with DNA: Influence of ionic strength and base composition. Biophys. Chem. 59, 155-170.
111. Silverman, Jr., S., Gorsky, M., and Lozada, F. (1984). Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53, 563-568.
112. Southard, G. L., Boulware, R. T., Walborn, D. R., Groznik, W. J., Thorne, E. E., and Yankell, S. L. (1984). Sanguinarine, a new antiplaque agent: Retention and plaque specificity. J. Am. Dent. Assoc. 108, 338-341.
113. Southard, G. L., Parson, L. G., Thomas Jr., L. G., Boulware, R. T., Woodall, I. R., and Jones, B. J. B. (1987a). The relationship of sanquinaria extract concentration and zinc ion to plaque and gingivitis. J. Clin. Periodontol. 14, 315-319.
114. Southard, G. L., Parsons, L. G., Thomas, L. G., Woodall, I. R., and Jones, B. J. B. (1987b). Effect of sanguinaria extract on development of plaque and gingivitis when supragingivally delivered as a manual rinse or under pressure in an oral irrigator. J. Clin. Periodontal. 14, 377-380. [Cited in Laster and Lobene, 1990]
115. Tandon, S., Das, M., and Khanna, S. K. (1993). Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs. Drug Metab. Dispos. 21, 194-197.
116. van der Waal, I., Schepman, K. P., van der Meij, E. H., and Smeele, L. E. (1997). Oral Leukoplakia: A clinicopathological review. Oral Oncol. 33(5), 291-301.
117. Vipont (1990). Nonimmunologic contact urticaria in guinea pigs (NICU). Vipont Pharmaceutical Co. Study HIM89-Vipont-NICU-1.
118. Walker, C. (1990). Effects of sanguinarine and sanguinaria extract on the microbiota associated with the oral cavity. J. Can. Dent. Assoc. 56(7), 13-17.
119. Wennström, J., and Lindhe, J. (1985). Some effects of a Sanguinarine-containing mouthrinse on developing plaque and gingivitis. J. Clin. Periodontol. 12, 867-872.
120. Wennström, J., and Lindhe, J. (1986). The effect of mouthrinses on parameters characterizing human periodontal disease. Compend. Cont. Educ. Dent. 7, S197-S204.
121. Werner, G. A., and Summerlin, D.-J. (1998). The relationship between Viadent uses and oral epithelial dysplasia. J. Dent. Res. 77(A). [Abstract 334]
122. Williams, G. M., and Weisburger, J. H. (1991). Chemical Carcinogenesis. In (Amdur, M. O., Doull, J., and Klaassen, C. D., Eds.), Casarett and Doull's Toxicology: The Basic Science of Poison, 4th ed., pp. 127-200. Pergamon Press.
123. Wink, M., Schmeller, T., and Latz-Brüning, B. (1998). Modes of action of allelochemical alkaloids: Interaction with neuroreceptors, DNA, and other molecular targets. J. Chem. Ecol. 42(11), 1881-1937.
124. Wright, J. M. (1998). A review and update of oral precancerous lesions. Tex. Dent. J. June, 15-19.
125. Yaari, A. M., and Yankell, S. L. (1982). Clinical Evaluation of Irritation of Sensitization of Vipont Laboratories Active and Placebo Dentrifice Formulations. University of Pennsylvania. Study No. 1001UP.
126. Yaari, A. M., and Yankell, S. L. (1983). Clinical Evaluation of Irritation or Sensitization of Vipont Laboratories Active and Placebo Mouthrinse Formulations. University of Pennsylvania. Study No. 1002UP.